Mercury Biopharmaceutical Corporation (TPEX: 6932)
Taiwan
· Delayed Price · Currency is TWD 15.20
+0.15 (1.00%)
Jan 21, 2025, 9:04 AM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 6.70 billion as of January 21, 2025. Its market cap has decreased by -16.56% in one year.
Market Cap
6.70B
Enterprise Value
6.48B
Revenue
5.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.20
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has increased from 5.10B to 6.70B, an increase of 31.25%. That is a compound annual growth rate of 13.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 6.70B | 21.84% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 235.68B |
| Caliway Biopharmaceuticals | 98.05B |
| Bora Pharmaceuticals Co., LTD. | 80.81B |
| Lotus Pharmaceutical | 69.14B |
| Lumosa Therapeutics | 40.11B |
| Oneness Biotech | 37.34B |
| Polaris Group | 32.38B |
| Center Laboratories | 29.18B |